Last reviewed · How we verify

NCT06834802

3D Analysis of Soft Tissue Healing After Immediate Implant Placement Using PRF Vs HAM

Active, enrolled NA Last updated 19 February 2025
What this trial tests

NA trial testing PRF in Badly Broken Maxillary Premolars Indicated for Extraction in 36 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
7 January 2025
Primary endpoint
1 August 2025
1 September 2025

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment36
Start date7 January 2025
Primary completion1 August 2025
Estimated completion1 September 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 60, any sex, with Badly Broken Maxillary Premolars Indicated for Extraction or Badly Broken Down Vital Teeth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Statement of the problem: Soft tissue healing following immediate implant placement is one of the major factors that affect implant restoration, function \& success. Aim: The aim of this study is to compare the effect of using HAM (Human amniotic membrane) and platelet rich fibrin (PRF) in soft tissue healing with immediate implant placement in the molar region.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of PRF

Trials testing the same drug.

Other recruiting trials for Badly Broken Maxillary Premolars Indicated for Extraction

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06834802.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing